Nateglinide is an N-acyl-D-phenylalanine derivative that functions as an orally administered, rapidly absorbed, short-acting insulinotropic agent. It is used as a hypoglycemic agent and an inhibitor of dipeptidyl-peptidase IV, primarily in the manufacturing of pharmaceutical products for type 2 diabetes mellitus.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 105816-06-6
Nateglinide
active pharmaceutical ingredient
D-Phenylalanyl Nateglinide
research compound
Nateglinide Methyl Ester
intermediate for nateglinide synthesis
Tropisetron hydrochloride
active pharmaceutical ingredient
Doxycycline hydrochloride
active pharmaceutical ingredient
CLINAFLOXACIN
investigational fluoroquinolone antibiotic
Clodronic Acid
Bone resorption inhibitor
Ent-Nateglinide
active pharmaceutical ingredient
(2R)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid
OELFLUMRDSZNSF-OFLPRAFFSA-N
CC(C)C1CCC(CC1)C(=O)N[C@H](CC2=CC=CC=C2)C(=O)O